PRESS RELEASE published on 03/19/2025 at 15:27, 1 year 5 months ago Inside Information / Other news releases Valerio Therapeutics announces new board members and their positions in other companies as of March 19, 2025 Board Members Positions Valerio Therapeutics Other Companies March 19 2025
BRIEF published on 03/19/2025 at 12:35, 1 year 5 months ago Valerio Therapeutics Board Meeting Decisions Director Changes Shareholder Meeting Share Split Board Resolutions Article Amendments
BRIEF published on 03/19/2025 at 12:35, 1 year 5 months ago Décisions du conseil d'administration de Valerio Therapeutics Assemblée Des Actionnaires Fractionnement Des Actions Changements De Directeur Résolutions Du Conseil D'administration Modifications D'articles
PRESS RELEASE published on 03/19/2025 at 12:30, 1 year 5 months ago Informations privilégiées / Autres communiqués Rapport du conseil d'administration de VALERIO THERAPEUTICS pour l'AG mixte des actionnaires du 9 avril 2025 concernant révocations, cooptations, division du nominal des actions et modifications statutaires Cooptation Revocation Valerio Therapeutics AG Mixte Division Du Nominal
PRESS RELEASE published on 03/19/2025 at 12:30, 1 year 5 months ago Inside Information / Other news releases Valerio Therapeutics Board of Directors convenes a General Meeting with resolutions on director dismissals, co-optation, share division, bylaws amendment, and formalities powers Board Of Directors General Meeting Resolutions Valerio Therapeutics Share Division
BRIEF published on 02/04/2025 at 10:40, 1 year 6 months ago Valerio Therapeutics opts for strategic refocusing Clinical Trials Oncology Financial Strategy Medical Innovation Valerio Therapeutics
BRIEF published on 02/04/2025 at 10:40, 1 year 6 months ago Valerio Therapeutics opte pour un recentrage stratégique Innovation Médicale Stratégie Financière Essais Cliniques Oncologie Valerio Therapeutics
PRESS RELEASE published on 02/04/2025 at 10:35, 1 year 6 months ago Inside Information / Other news releases Valerio Therapeutics refocuses strategy, discontinuing clinical trials for financial reasons. Focus on early-stage drug development Clinical Trials Financial Challenges Valerio Therapeutics Strategy Refocus Early-stage Development
PRESS RELEASE published on 02/04/2025 at 10:35, 1 year 6 months ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce un recentrage stratégique pour se concentrer sur le développement de médicaments early-stage et assurer une croissance durable. La société cherche un accord de financement à long terme Développement Financement Restructuration Médicaments Valerio Therapeutics
BRIEF published on 10/01/2024 at 00:56, 1 year 10 months ago Valerio Therapeutics Reports First Half 2024 Financial Results Financial Results R&D Clinical Trial Valerio Therapeutics Single Domain Antibodies
Published on 08/22/2026 at 05:50, 7 hours 13 minutes ago Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 8 hours 8 minutes ago Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 12 hours 33 minutes ago BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 14 hours 3 minutes ago Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/21/2026 at 23:00, 14 hours 3 minutes ago Silver Storm Announces $7.5 Million Non-Brokered Private Placement with Eric Sprott
Published on 08/21/2026 at 19:36, 17 hours 27 minutes ago EQS-Adhoc: KAP AG ANNOUNCES CHANGE IN SHAREHOLDER STRUCTURE
Published on 08/21/2026 at 19:11, 17 hours 51 minutes ago EQS-Adhoc: Marley Spoon Group SE: Discussions with Misfits Market as permanent US fulfillment agent
Published on 08/21/2026 at 18:14, 18 hours 48 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/21/2026 at 17:27, 19 hours 36 minutes ago EQS-Adhoc: PSI Adjusts Its Forecast for Fiscal Year 2026 in Light of Economic Uncertainties in Europe
Published on 08/21/2026 at 16:30, 20 hours 33 minutes ago BL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades
Published on 08/21/2026 at 18:33, 18 hours 30 minutes ago 260821 BENETEAU Transaction sur actions propres
Published on 08/18/2026 at 18:00, 3 days 19 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 3 days 19 hours ago Mise à disposition du rapport financier annuel 2025-26
